Harvey Capital Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Harvey Capital Management Inc

$464 Million
Q3 2025

A detailed history of Harvey Capital Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Harvey Capital Management Inc holds 11,402 shares of REGN stock, worth $7.91 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares

11,402

Previous 11,742 2.9%

Holding current value

$7.91 Million

Previous $6.16 Million 4.01%

% of portfolio

1.38%

Previous 1.45%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 31, 2025	SELL	$534.91 - $598.71 $181,869 - $203,561	-340 Reduced 2.9%	11,402 $6.41 Million
Q2 2025 Aug 14, 2025	SELL	$483.07 - $625.6 $652,144 - $844,560	-1,350 Reduced 10.31%	11,742 $6.16 Million
Q1 2025 Apr 30, 2025	BUY	$634.14 - $744.83 $17,755 - $20,855	28 Added 0.21%	13,092 $8.3 Million
Q4 2024 Jan 29, 2025	BUY	$701.85 - $1046.91 $169,847 - $253,352	242 Added 1.89%	13,064 $9.31 Million
Q3 2024 Oct 29, 2024	SELL	$1024.09 - $1201.76 $35,843 - $42,061	-35 Reduced 0.27%	12,822 $13.5 Million

Q2 2024 Jul 22, 2024	SELL	$883.2 - $1071.19 $61,824 - $74,983	-70 Reduced 0.54%	12,857 $13.5 Million
Q1 2024 May 10, 2024	SELL	$902.69 - $993.35 $69,507 - $76,487	-77 Reduced 0.59%	12,927 $12.4 Million
Q4 2023 Jan 29, 2024	SELL	$775.18 - $881.7 $98,447 - $111,975	-127 Reduced 0.97%	13,004 $11.4 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $20,773 - $25,331	-30 Reduced 0.23%	13,131 $10.8 Million
Q2 2023 Aug 04, 2023	BUY	$700.03 - $830.35 $406,717 - $482,433	581 Added 4.62%	13,161 $9.46 Million
Q1 2023 May 17, 2023	SELL	$680.49 - $826.97 $95,268 - $115,775	-140 Reduced 1.1%	12,580 $10.3 Million
Q4 2022 Feb 27, 2023	SELL	$705.89 - $766.39 $7,058 - $7,663	-10 Reduced 0.08%	12,720 $9.18 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $1.77 Million - $2.23 Million	-3,080 Reduced 19.48%	12,730 $8.77 Million
Q2 2022 Aug 08, 2022	SELL	$548.35 - $738.84 $593,863 - $800,163	-1,083 Reduced 6.41%	15,810 $9.35 Million
Q1 2022 Apr 22, 2022	BUY	$595.12 - $698.43 $58,321 - $68,446	98 Added 0.58%	16,893 $11.8 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $561,414 - $693,112	1,033 Added 6.55%	16,795 $10.6 Million
Q3 2021 Oct 25, 2021	SELL	$574.03 - $680.96 $803,642 - $953,344	-1,400 Reduced 8.16%	15,762 $9.54 Million
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $2.89 Million - $3.41 Million	6,105 Added 55.21%	17,162 $9.59 Million
Q1 2021 May 07, 2021	BUY	$446.73 - $548.2 $4.94 Million - $6.06 Million	11,057 New	11,057 $5.23 Million
Q4 2020 Feb 10, 2021	SELL	$478.3 - $607.98 $191,320 - $243,192	-400 Closed	0 $0
Q3 2020 Oct 27, 2020	SELL	$544.75 - $658.21 $27,237 - $32,910	-50 Reduced 11.11%	400 $223,000
Q2 2020 Aug 05, 2020	BUY	$493.32 - $643.92 $221,994 - $289,764	450 New	450 $280,000

Others Institutions Holding REGN

# of Institutions

1,501

Shares Held

86.6M

Call Options Held

2.38M

Put Options Held

1.61M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvey Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Harvey Capital Management Inc with notifications on news.

Account

Harvey Capital Management Inc Regeneron Pharmaceuticals, Inc. Transaction History